Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…
Copenhagen, March 2022 With assistance from Gemstone Capital, DecideAct has raised DKK 5,2 million from Jesper Munch, an existing investor in the Company. The issue was priced 10 percent above the ten-day weighted average share price, equal to DKK 8,21 per share. Jens Munch says: “DecideAct is developing well. Right now, times are turbulent,…
Copenhagen, October 2022 Brain+ has successfully completed the exercise window of their IPO warrants of TO1, with a subscription percentage of 82%, which is equivalent to DKK 6,4 million. The Company will thus receive DKK 6,4 million in capital before issuing costs. The Company is pleased with the exercise, which took place at DKK 1,638…